No CrossRef data available.
Article contents
Administrative Developments: Celera Genomics to Complete DNA Map
Published online by Cambridge University Press: 01 January 2021
Extract
On April 6, 2000, Dr. J. Craig Venter of Celera Genomics told a Congressional committee that his company finished its analysis of the human DNA and would have a completed map of the human genome by early summer, 2000. Scientists expect the completed human genome to revolutionize drug therapies through the creation of treatments tailored to specific genetic makeups. In order to create a map of the human genome, three billion letters of DNA that encode eighty thousand genes must be identified and ordered. In March, 2000, Celera released a successful sequence of the fruit fly genome, and it employed the same methods in creating the human genome.
- Type
- Article
- Information
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 2000
References
See “Hearings Before the Subcomm. on Energy and the Environment of the House Comm. on Science,” 106th Cong. (2000) (statement of J.C. Venter, President and Chief Scientific Officer of Celera Genomics).Google Scholar
See Wade, N., “Two Groups in DNA Race Differ on Fixing Project's Finish Line,” N.Y. Times, April 11, 2000, at A27.Google Scholar
See Myers, S.L., “Assembling of the Genome is at Hand,” N.Y. Times, April 7, 2000, at A20.Google Scholar
See “Hearings Before the Subcomm.,” supra note 1.Google Scholar
See Myers, supra note 3, at A20.Google Scholar
See Wade, supra note 2, at A27.Google Scholar
See id.Google Scholar
See “Hearings Before the Subcomm.,” supra note 1.Google Scholar
See id.Google Scholar
See id.Google Scholar
See id.Google Scholar
See id.Google Scholar
See Friedan, A.C., “Regulating Gene Data,” The National Law Journal, March 27, 2000, at C1.Google Scholar
See id.Google Scholar
See “Hearing Before the Subcomm.,” supra note 1.Google Scholar
See id.Google Scholar
See id.Google Scholar